Prostate Cancer & Men's Cancer News
Castrate-Resistant Pre-chemotherapy
- Provenge (Spicucel-T) immunotherapy
- A Phase 3 Randomized Trial Comparing TAK-700 Plus Prednisone with Placebo Plus Prednisone in Patients with Chemotherapy Naieve Metastatic Castration Resistant Prostate Cancer
Chemotherapy
- A PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF DOCETAXEL AND PREDNISONE WITH OR WITHOUT LENALIDOMIDE IN SUBJECTS WITH CASTRATE-RESISTANT PROSTATE CANCER
Post Taxotere
- A Phase 3 Randomized Trial Comparing TAK-700 Plus Prednisone with Placebo Plus Prednisone in Patients with Metastatic Castration Resistant Prostate Cancer That Has Progressed During or Following Docetaxel Based Therapy
- Provenge (Spicucel-T) immunotherapy
Heavily pretreated population
- A Phase 1, First-in-Human Study Evaluating the Safety, Tolerability, and Pharmacokinetics of AMG 337 in Adult Subjects with Advanced Solid Tumors